Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study by Schuler, Martin, Prof, Cho, Byoung Chul, MD, Sayehli, Cyrus Michael, MD, Navarro, Alejandro, MD, Soo, Ross A, MBBS, Richly, Heike, MD, Cassier, Philippe Alexandre, MD, Tai, David, MBBS, Penel, Nicolas, MD, Nogova, Lucia, MD, Park, Se Hoon, MD, Schostak, Martin, MD, Gajate, Pablo, MD, Cathomas, Richard, MD, Rajagopalan, Prabhu, PhD, Grevel, Joachim, PhD, Bender, Sebastian, PhD, Boix, Oliver, PhD, Nogai, Hendrik, MD, Ocker, Matthias, MD, Ellinghaus, Peter, PhD, Joerger, Markus, MD

Get full text

Ileal neuroendocrine tumors show elevated activation of mammalian target of rapamycin complex by Geis, Christian, MD, Fendrich, Volker, MD, Rexin, Peter, MD, Di Fazio, Pietro, PhD, Bartsch, Detlef K., MD, Ocker, Matthias, MD, Quint, Karl, MD, Heverhagen, Anna E., MD

Get full text